This chapter discusses a study comparing the effects of hydro-corrosone to placebo on survival without moderate or severe bronchopulmonary dysplasia (BPD) at 36 weeks post menstrual age and neurodevelopmental impairment at two years. While no statistically significant difference was found, the chapter highlights the small suggestion of a benefit for hydro-corrosone in terms of survival without BPD. It also explores secondary analyses based on baseline risk and severity of lung disease.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode